Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs

BackgroundAntibody-based regimens targeting programmed cell death protein-1 (PD-1)/programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor (VEGFR) include conventional PD-1/PD-L1 inhibitors combined with anti-angiogenic monoclonal a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wenjie Mao, Zeqi Tang, Yu Chen, Yixia Chen, Shiyan Zhang, Xiaoling Feng, Shengying Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-06-01
coleção:	Frontiers in Immunology
Assuntos:	anti-angiogenic monoclonal antibodies meta-analysis NSCLC PD-1/PD-L1 inhibitors prognosis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1847913/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!